About us

Why do we work on Alzheimer’s?

The brains of aging humans are prone to neurodegenerative disorders and we are unable to counteract neuronal loss by regenerating lost cells. Patients with neurodegenerative conditions progressively loose neurons yet cannot form new neurons that would replace the lost ones. We are using zebrafish and novel 3D human culture systems as models to investigate the vertebrate neural stem cells, which we believe are the hope to bring back our lost neurons. We want to find ways how we can restore our brain function in fighting against Alzheimer’s! Additionally, many genes are associated with increased risk of Alzheimer’s disease but we are not in full understanding on how those genes contribute to the pathology of Alzheimer’s disease. Our models are helping to elucidate those functions.

What makes our work different?

Zebrafish regenerates its brain successfully even in Alzheimer’s disease conditions. Our goal is to learn from zebrafish how we can enable the  human brain to better cope with neurodegenerative disease and regenerate. We have a unique model to work with. Zebrafish also offers excellent opportunities for functional and translational genomics toolkit for Alzheimer’s disease research. We bring together basic science, technology development, drug screening and development, disease modeling and computation in one animal model, and feed our science from world leading clinical studies and Alzheimer’s disease cohorts.

The motivations of our research group is (1) to understand the molecular programs zebrafish brain uses to induce regenerative stem cell plasticity, (2) harness this knowledge to unlock the regenerative potential of our brains in Alzheimer’s disease conditions, (3) develop new functional genomics models in zebrafish to study the function of Alzheimer’s disease-related genes, and (4) to use zebrafish as a pre-clinical animal model for our novel first-in-class multi-target directed ligand compounds. Check out our publications and presence in the media.

Our lab culture

Our team is composed of young and ambitious scientists. In the last 9 years, our team members came from 21 countries of 5 continents, with diverse backgrounds. Kizil Lab derives its success from this richness that cultivates a positive dialogue, gender equality, inclusion and openness. With our non-hierarchical approaches to discussions and management, we created a true melting pot where many scientists outside of our lab also aspire to join. Thanks to our lab culture that respects differences and promotes productive team work, our team members bring their extraordinary input and enthusiasm into the new projects. We believe that the team spirit and the congruence generated in Kizil Lab is the reason behind our success.

Announcements

We found a genetic variant that protects against Alzheimer’s disease

We discovered a genetic variant that reduces the odds of developing Alzheimer’s disease by up to 70% and may be protecting hundreds of thousands of people from the disease. The discovery of the protective variant, which appears to allow toxic forms of amyloid out of the brain and through the blood-brain barrier, supports emerging evidence that …

Our collaborative study identified a protective genetic variant in humans that protects against Alzheimer’s disease

We are glad to announce another preprint from our lab. We have discovered rare genetic variations in a gene associated with the extracellular matrix (ECM) that might protect against Alzheimer’s disease for those at higher genetic risk, specifically individuals carrying the APOEe4 allele. The study used whole genome sequencing data from different cohorts to isolate …

Contact

We are located at

Department of Neurology and The Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Irving Medical Center, 650 W 168th St, New York, NY, 10032

650 W 168th Street,
New York, NY 10032

Proudly Powered by WordPress

.